Bertholletia excelsa
Bertholletia excelsa has been studied in 2 papers since 2022: 1 trial in people, 1 review; 1 in the past year. The newest paper, Feb 11, 2026: “Supplementation with mixed nuts does not improve inflammatory biomarkers or dietary inflammatory potential in post-myocardial infarction: a secondary analysis of the DICA-NUTS trial”.
2 papers study it2 findingsUpdated
See all 2 papers on bertholletia excelsa
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and 2 more
- Human trial1
What did studies of bertholletia excelsa find?
2Studies of bertholletia excelsa measured 2 outcomes: cognitive function and fasting glucose.
Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
Bertholletia excelsa improves cognitive function in older adults with mild cognitive impairment.
“Older adults with mild cognitive impairment improved verbal fluency and constructional praxis”
Reviewin older adults with mild cognitive impairment
Foods (Basel, Switzerland)
Fasting glucose
downin humans1
1 study
Fasting glucose
downin humans1
Bertholletia excelsa decreases fasting glucose in healthy subjects.
“In addition, healthy subjects improved lipid markers and fasting glucose.”
Reviewin healthy subjects
Foods (Basel, Switzerland)